SCHEMBL4053675

SCHEMBL4053675

CC(=O)c1ccc(-c2cnc(CN(C)C3CCN(c4ncccn4)CC3)cn2)s1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2A6 P11509 1/20 0.37
CYP2C9 P11712 1/20 0.37
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
MCHR1 Q99705 1/20 0.36
KDM4E B2RXH2 5/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 1/20 0.36
RECQL P46063 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ALDH1A1 P00352 5/20 0.35
SLC6A7 Q99884 1/20 0.35
TSHR P16473 1/20 0.34
HDAC1 Q13547 1/20 0.34
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4053679 0.86 ADRA1D (0.34) CYP2C19CYP3A4CYP2C9MCHR1KDM4E
SCHEMBL4048819 0.81 GPR119 (0.40) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL4543729 0.79 MCHR1 (0.43) CYP2C19CYP3A4CYP2C9MCHR1KDM4E
SCHEMBL4371632 0.79 UBE2M (0.41) TSHR
SCHEMBL4050817 0.72 GPR119 (0.40) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL4057702 0.72 GPR119 (0.48) CYP3A4
SCHEMBL4543839 0.71 GPR119 (0.41) CHRM4MCHR1KDM4EMAPK1
SCHEMBL4374631 0.68 ITGB3 (0.40) MCHR1KDM4EALDH1A1HDAC1
SCHEMBL13690604 0.67 RXFP1 (0.41) MCHR1KDM4ENPC1RAB9AHSD17B10
SCHEMBL4051798 0.67 SCN9A (0.39) CYP2C19CYP3A4CYP2C9KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009106561-A1 PYRAZINE COMPOUNDS FOR TREATING GPR119 RELATED DISORDERS BIOVITRUM AB (PUBL) (SE) 2009-09-03 WO disclosed
WO-2009106561-A1 PYRAZINE COMPOUNDS FOR TREATING GPR119 RELATED DISORDERS BIOVITRUM AB (PUBL) (SE) 2009-09-03 WO disclosed